Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16550046

Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations

Author
MACKEY, John R; GALMARINI, Carlos M; HANSON, John; YOUNG, James D; MERLE-BERAL, Helene; BINET, Jacques L; CASS, Carol E; DUMONTET, Charles; GRAHAM, Kathryn A; JOY, Anil A; DELMER, Alain; DABBAGH, Laith; GLUBRECHT, Darryl; JEWELL, Lawrence D; LAI, Raymond; LANG, Thack
Cross Cancer Institute, Edmonton, Alberta, Canada
Departments of Oncology, Laboratory Medicine and Pathology, and Physiology, University of Alberta, Alberta, Canada
Hotel Dieu, Paris, France
Hôpital de la Pitié Salpétrière, Parιs, France
Unité INSERM 590, Centre Leon Bérard, Lyon, France
University Claude Bernard, Lyon, France
Source

Blood. 2005, Vol 105, Num 2, pp 767-774, 8 p ; ref : 37 ref

ISSN
0006-4971
Scientific domain
Medical oncology; Hematology
Publisher
The Americain Society of Hematology, Washington, DC
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Analyse quantitative Anticancéreux Chronique Expression génique Fludarabine Homme Leucémie lymphoïde Métabolisme Nucléoside Résistance traitement Transport biologique Analogue nucléotide Antimétabolite Hémopathie maligne Lymphoprolifératif syndrome Purine nucléotide
Keyword (en)
Quantitative analysis Antineoplastic agent Chronic Gene expression Fludarabine Human Chronic lymphocytic leukemia Metabolism Nucleoside Treatment resistance Biological transport Antimetabolic Malignant hemopathy Lymphoproliferative syndrome Purine nucleotide
Keyword (es)
Análisis cuantitativo Anticanceroso Crónico Expresión genética Fludarabina Hombre Leucemia linfoidea Metabolismo Nucleósido Resistencia tratamiento Transporte biológico Antimetabólito Hemopatía maligna Linfoproliferativo síndrome Purina nucleótido
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis

Discipline
Blood diseases Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
16550046

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web